Literature DB >> 4695229

Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system.

S Rockwell, R F Kallman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4695229

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  23 in total

1.  Influence of scheduling on two-drug combinations of alkylating agents in vivo.

Authors:  B A Teicher; S A Holden; S M Jones; J P Eder; T S Herman
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia.

Authors:  T S Herman; B A Teicher; M R Pfeffer; V S Khandekar; E Alvarez Sotomayor
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 3.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.

Authors:  B A Teicher; S A Holden; V Khandakar; T S Herman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 5.  Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress.

Authors:  Mark W Dewhirst
Journal:  Radiat Res       Date:  2009-12       Impact factor: 2.841

6.  Development of an in vitro colony formation assay for the evaluation of in vivo chemotherapy of a rat brain tumor.

Authors:  M L Rosenblum; K D Knebel; K T Wheeler; M Barker; C B Wilson
Journal:  In Vitro       Date:  1975 Sep-Oct

Review 7.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

8.  CAI: effects on cytotoxic therapies in vitro and in vivo.

Authors:  B A Teicher; S A Holden; Y N Chen; G Ara; T T Korbut; D Northey
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.

Authors:  S S Pan; S A Akman; G L Forrest; C Hipsher; R Johnson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Effect of tumor dissaggregation on results of in vitro cell survival assay after in vivo treatment of the EMT-6 tumor: x-rays, cyclophosphamide, and bleomycin.

Authors:  J S Rasey; N J Nelson
Journal:  In Vitro       Date:  1980-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.